Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
40.21B
Market cap40.21B
Price-Earnings ratio
29.32
Price-Earnings ratio29.32
Dividend yield
Dividend yield
Average volume
4.48M
Average volume4.48M
High today
$69.02
High today$69.02
Low today
$67.85
Low today$67.85
Open price
$68.10
Open price$68.10
Volume
4.25M
Volume4.25M
52 Week high
$96.12
52 Week high$96.12
52 Week low
$58.93
52 Week low$58.93

EW News

Simply Wall St 7d
Edwards Lifesciences Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Advertisement Edwards Lifesciences ( ) Full Year 2024 Results Key Financial Results Revenue: US$5.44b (up 8.6% from FY 2023). Net income: US$1.40b (up 14% f...

Edwards Lifesciences Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Analyst ratings

53%

of 32 ratings
Buy
43.8%
Hold
53.1%
Sell
3.1%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.